| The incidence rate of seizures in relation to BMI in UK adults. |
| Author(s): Gao S, Juhaeri J & Dai WS |
| Affiliations(s): Global Pharmacovigilance and Epidemiology, Sanofi-Aventis, Bridgewater, New Jersey
|
| Publication(s): Obesity (Silver Spring). 2008 Sep;16(9):2126-32. doi: 10.1038/oby.2008.310. |
| Document Type(s): Abstract, Article |
| Countries: UK |
| Click here for the abstract |
C:
Y: |
Mental health, Neurological disorders, Obesity
2008 |
|
L:
A: |
English
Retrospective database analysis |
|
 |
| |
| |
| Long-term cost-effectiveness of rimonabant in Germany |
| Author(s): Pirk O1, Hessel F2, Kotowa W1, Hertel N1 |
| Affiliations(s): 1 IMS Health, Nuremberg, Germany 2 Sanofi Aventis Deutschland, Berlin, Germany |
Publication(s): ISPOR 10th Annual European Congress, 20-23 October 2007, Dublin, Irel
Value in Health 10 (6): A 414 |
| Document Type(s): Abstract, Oral presentation |
| Countries: Germany |
C:
Y: |
Obesity
2007 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Clinical management and economic impact of cardiovascular risk factors monitoring in obese and overweight patients in primary care |
| Author(s): Polanco Sánchez C, Franch Nadal J, Layola Brias M, Lara Suriñach N |
| Affiliations(s): |
| Publication(s): Revista Española de Economía de la Salud 2007;6(8):436-46 |
| Document Type(s): Article |
| Countries: Spain |
C:
Y: |
Obesity
2007 |
|
L:
A: |
Spanish
Market impact |
|
|
| |
| |
| Costs of premature death attributed to obesity in Spain. |
| Author(s): Echevarria A, Betegón L, Badia X. |
| Affiliations(s): |
| Publication(s): ISPOR 11th Annual International Meeting. Philadelphia, Pennsylvania (USA) |
| Document Type(s): Poster |
| Countries: Spain |
C:
Y: |
Obesity
2006 |
|
L:
A: |
English
Burden of illness |
|
|
| |
| |
| Diagnosis and treatment flows for morbidly obese patients visiting physician offices in the US |
| Author(s): Pokras SM, Klingman D, Tierce JC |
| Affiliations(s): |
| Publication(s): Value in Health 2008;11,3 (May/June);Poster presented at the 13th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Toronto, Ontario, Canada, May 3-7, 2008 |
| Document Type(s): Poster |
| Countries: USA |
C:
Y: |
Obesity
2006 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Long-term cost-effectiveness of zoledronic acid versus risedronate in patients with Paget's disease of the bone in Germany |
| Author(s): Kurth AA1 , Kotowa W2, Goel D3, Maiwenn JA4 |
| Affiliations(s): 1 Orthopaedische Universitaetsklinik Stiftung Friedrichsheim, Frankfurt am Main, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma GmbH, Nuremberg, Germany 4 Institute for Medical Technology Assessment, Erasmus Medical Center, Rotterdam, Netherlands |
| Publication(s): ECCEO 6, 2006, March 15-18, Vienna, Austria |
| Document Type(s): Oral presentation |
| Countries: Germany |
C:
Y: |
Obesity
2006 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Zoledronic acid in the long-term management of Paget's disease of the bone in Germany - a cost savings approach? |
| Author(s): Kurth AA1, Kotowa W2, Fricke F-U2, Quednau K3, Maiwenn JA4 |
| Affiliations(s): 1 Orthopaedische Universitaetsklinik Stiftung Friedrichsheim, Frankfurt am Main, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma GmbH, Nuremberg, Germany 4 Institute for Medical Technology Assessment, Erasmus Medical Center, Rotterdam, Netherlands |
| Publication(s): ISPOR 9th Annual International Congress, 29-31 October 2006, Copenhagen, Denmark |
| Document Type(s): Oral presentation |
| Countries: Germany |
C:
Y: |
Obesity
2006 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Zoledronic acid in the long-term management of Paget's disease of the bone in Germany - a cost savings approach? |
| Author(s): Kurth AA1, Kotowa W2, Fricke F-U2, Quednau K3, Maiwenn JA4 |
| Affiliations(s): 1 Orthopaedische Universitaetsklinik Stiftung Friedrichsheim, Frankfurt am Main, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma GmbH, Nuremberg, Germany 4 Institute for Medical Technology Assessment, Erasmus Medical Center, Rotterdam, Netherlands |
| Publication(s): Value in Health 2006, 9(6) |
| Document Type(s): Abstract |
| Countries: Germany |
C:
Y: |
Obesity
2006 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Long-term cost-effectiveness of zoledronic acid versus risedronate in patients with Paget's disease of the bone in Germany |
| Author(s): Kurth AA1 , Kotowa W2, Goel D3, Maiwenn JA4 |
| Affiliations(s): 1 Orthopaedische Universitaetsklinik Stiftung Friedrichsheim, Frankfurt am Main, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma GmbH, Nuremberg, Germany 4 Institute for Medical Technology Assessment, Erasmus Medical Center, Rotterdam, Netherlands |
| Publication(s): ECCEO 6, 2006, March 15-18, Vienna, Austria |
| Document Type(s): Abstract |
| Countries: Germany |
C:
Y: |
Obesity
2006 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
 3 of 3
|
